Biotech

All Articles

FibroGen lays off 75% of US personnel as property fails 2 more tests

.FibroGen is drastically restructuring its organization, giving up 75% of its own USA workers as wel...

Tracon relax weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has actually decided to relax procedures full weeks after an injectable invu...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...

Takeda takes $140M reduction on neglected epilepsy drug, touts FDA operate

.Our experts already know that Takeda is actually wishing to discover a path to the FDA for epilepsy...

VBI Injections apply for personal bankruptcy, seeks asset sale

.Immunology biotech VBI Injections is actually turning dangerously close to the moment of truth, wit...

Celldex anti-cKIT antibody lessen colonies in an additional phase 2 research study

.It's difficult to muscle mass in on a space as affordable as immunology, however Celldex Rehabs thi...

Boehringer provides to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapeutics as well as a preclinical i...

Ventyx's last resort for inflamed med sides in Crohn's failure

.Ventyx Biosciences' Crohn's ailment medication did not aid individuals obtain remission in a stage ...

Cognition's phase 2 sparkle data taint Alzheimer's prospect

.Knowledge Therapies' period 2 SHINE trial has actually taken several of the radiance off the Alzhei...

BMS centers bispecific months after filing to work period 3 trial

.Bristol Myers Squibb has possessed a whiplash change of heart on its own BCMA bispecific T-cell eng...